# Alverno Laboratories selects Ibex's AI platform for cancer diagnostics

Alverno Laboratories, a large U.S. laboratory network, selected Ibex Medical Analytics' AI-powered Galen platform to support pathologists in cancer diagnosis. The deal was announced on August 11, 2021.

- Type: Contract
- Announced: 2021-08-11
- Where: Hammond, Indiana, United States
- Status: completed
- Products: AI-powered cancer diagnostics platform, Galen platform
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Alverno Laboratories](https://endata.com/companies/57044.md) (customer)
- [Ibex Medical Analytics](https://endata.com/companies/57045.md) (supplier)

## Sources

- [prnewswire.com](https://www.prnewswire.com/news-releases/alverno-laboratories-selects-ibexs-ai-solution-for-cancer-diagnostics-301353121.html), 2021-08-11: "Ibex transforms cancer diagnosis by harnessing Strong AI and machine learning technology at an unprecedented scale."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.